Last updated on July 2017

Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign .

Brief description of study

The purpose of this study is to assess the early safety and performance of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for the treatment of symptomatic chronic functional tricuspid regurgitation (FTR). The procedure will be performed with the PTVAS device using a non-surgical percutaneous approach to tricuspid valve repair in patients who have FTR with a minimum of moderate tricuspid regurgitation.

Detailed Study Description

A prospective, single-arm, multi-center study, enrolling symptomatic patients with chronic functional tricuspid regurgitation and whom left-sided valve surgery is not planned. The study will include up to 30 subjects from up to 6 sites. Follow-up evaluations will be conducted through 2-years post implantation.

Clinical Study Identifier: NCT02574650


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Saibal Kar, MD

Cedars-Sinai Medical Center
Los Angeles, CA United States
  Connect »

Lowell Satler, MD

MedStar Washington Hospital Center
Washington, D.C., United States
  Connect »

Brijeshwar Maini, MD

Delray Medical Center
Delray Beach, FL United States
  Connect »

Christopher Meduri, MD

Piedmont Healthcare
Atlanta, GA United States
  Connect »

Stuart Rich, MD

Northwestern University / Bluhm Cardiovascular Institute
Chicago, IL United States
  Connect »

Rebecca Hahn, MD

Columbia University Medical Center / New York-Presbyterian Hospital
New York, NY United States
  Connect »

Scott Lim, MD

University of Virginia
Charlottesville, VA United States
  Connect »